this post was submitted on 23 Nov 2024
32 points (92.1% liked)

Health - Resources and discussion for everything health-related

2401 readers
855 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 2 years ago
MODERATORS
 

Summary

As many as 1 in 5 patients may not lose significant weight with GLP-1 drugs like Wegovy and Ozempic, despite their popularity and effectiveness in clinical trials.

Experts attribute this variability to genetic, hormonal, and brain-based differences in regulating energy, as well as factors like sleep apnea or medications that hinder weight loss.

Non-responders often face frustration, but doctors stress alternative options, including different medications, lifestyle adjustments, or older treatments.

top 7 comments
sorted by: hot top controversial new old
[–] [email protected] 17 points 1 month ago (2 children)

“As many as” 20% so, less than 20%? So it’s more than 80% effective?

[–] [email protected] 14 points 1 month ago

The article is about that 20% and how they’re feeling pretty shitty after taking a drug that works for 80% and not seeing weightloss despite the significant hype. It’s basically obesity experts trying to calm expectations slightly—the drug works for a lot of people but you can’t count on it being a magic bullet for everyone.

[–] [email protected] 6 points 1 month ago

hahah yeah what an ass-backwards way of attempting shit on efficacy

[–] [email protected] 8 points 1 month ago

To be honest, 80% effectiveness for a generation 2 of a long term drug is a pretty nice value, especially in this field and the regulatory mechanisms it affects.

That's better than basically most psychiatric, antivirals, antihypertensive and antidiabetic medication.

Only a few long term drugs like contraceptives, some chemotherapeutics and some hormone replacement drugs work that well in that many cases. And most of them are not Gen 2 drugs in a new field.

[–] paraphrand 5 points 1 month ago

What, you’re saying weight is complicated and not just down to one factor for everyone?!

It’s cool we have proof of this via the magic drugs.

[–] IsThisAnAI 2 points 1 month ago

I'll take my chances after continued testing. 80% is great.

[–] [email protected] 1 points 1 month ago

I wonder if they will respond better to retatrutide, since it's a glucagon triple agonist.